's general knowledge that the liver cancer cell can often go against and become a full member

's general knowledge that the liver cancer cell can often go against and become a full member
" reverses " of cancer ,It has been a hot issue all the time in recent years. So-called " reverse " The ones that said are a bit more popular, but transform the cancer cell already formed into normal cells. Can play the medicine on this kind of function, it induces differentiating pharmaceuticals to name. Induce and split up pharmaceuticals, the one that can be employed at clinic already, first kind names " link first sour against type all " ,Or is abbreviated as " Link first acid " . Link first acid in treating hepatocarcinoma, what great meaning is there on earth? In the laboratory, have already verified, he can make people's liver cancer cell is from the shape to every indexed, it is normal to tend to. How about in clinic? In recent years, explore this question from clinic, the result is exciting.
Some hepatocarcinoma patients have already performed the operation, have excised the visible cancer cell, but in the blood is tested, first child albumen - -The index of hepatocarcinoma of this reflection, it is still quite high. It means, there is potential liver cancer cell that exists. If does not treat, these cancer cells will be developed in some time, hepatocarcinoma will show again. Treated to some patients by linking first acid, found finally, nearly first child protein of 40% of the patients could be reduced, some of them can even return to normal. Indicate to link first acid to some potential liver cancer cells, can treat value. In addition, there are some hepatocarcinoma patients, can't already excise surgery, but can also use the radiotherapy, or get involved and treat, there can be suitable results. However, through such therapeutic patient, some first child albumens do not drop, or does not resume the normal one. We treat by linking first acid too, find that the same as the test above, many patients' first fetus albumen level has dropped too, even resume the normal one too. Explain it to the residual cancer cell treated, there is certain therapeutic value too.
As for to the hepatocarcinoma patient of later period, not finding obvious treatment value, but there is some improvement on symptom, the focus is steady, have. As a medicine, also need constant research. Like all medicines, it has certain side effects. Its application has a certain limit too. So, patient and his relative, can't use medicine blindly, mustn't go on under the guidance of doctor.
|